NVAX
Novavax, Inc.
Price Chart
Latest Quote
$9.00
+0.00 (+0.00%)
Current Price
| Previous Close | $9.00 |
| Open | $8.81 |
| Day High | $9.59 |
| Day Low | $8.81 |
| Volume | 4,123,092 |
Stock Information
| Shares Outstanding | 164.44M |
| Total Debt | $295.06M |
| Cash Equivalents | $790.33M |
| Revenue | $596.34M |
| Net Income | $-87.83M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $1.48B |
| EPS (TTM) | $-0.56 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $984.67M |
| Sales | $596.34M |
| Income | $-87.83M |
| Book/sh | $-0.88 |
| Cash/sh | $4.81 |
| Employees | 749 |
Financial Ratios
| Quick Ratio | 2.38 |
| Current Ratio | 2.48 |
Returns & Margins
| ROA | 1.99% |
| Gross Margin | 27.49% |
| Operating Margin | -7.19% |
| Profit Margin | -14.73% |
Ownership
| Insider Ownership | 5.01% |
| Institutional Ownership | 69.57% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -16.59 |
| PEG | 1.32 |
| P/S | 2.48 |
| P/B | -10.23 |
Analyst Data
| Recommendation | buy |
| Target Price | $14.11 |
Technical Indicators
| SMA20 | $9.61 |
| SMA50 | $9.07 |
| SMA200 | $8.48 |
| RSI | 32.76 |
| ATR | 0.6250 |
| Shares Float | 141.47M |
| Short Float | 28.13% |
| Short Ratio | 7.31 |
| Volatility | 2.41 |
| Rel Volume | 0.79 |
Performance History
| Week | -2.28% |
| Month | +0.22% |
| Quarter | -7.41% |
| 6 Months | +34.73% |
| YTD | +26.23% |
| Year | +40.41% |
| 3 Years | +11.66% |
| 5 Years | -95.19% |
| 10 Years | -93.24% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-23 | $9.00 | 4,123,092 |
| 2026-06-22 | $9.00 | 3,706,400 |
| 2026-06-18 | $9.13 | 9,458,300 |
| 2026-06-17 | $9.50 | 3,901,700 |
| 2026-06-16 | $9.20 | 4,168,400 |
| 2026-06-15 | $9.21 | 3,573,000 |
| 2026-06-12 | $8.88 | 2,591,600 |
| 2026-06-11 | $9.03 | 3,573,400 |
| 2026-06-10 | $8.56 | 3,098,800 |
| 2026-06-09 | $8.67 | 4,589,800 |
| 2026-06-08 | $8.62 | 6,864,200 |
| 2026-06-05 | $9.49 | 4,583,800 |
| 2026-06-04 | $10.19 | 5,248,600 |
| 2026-06-03 | $10.20 | 3,090,600 |
| 2026-06-02 | $10.21 | 4,653,000 |
| 2026-06-01 | $10.51 | 4,682,700 |
| 2026-05-29 | $10.97 | 7,154,000 |
| 2026-05-28 | $10.32 | 7,442,200 |
| 2026-05-27 | $11.09 | 9,799,900 |
| 2026-05-26 | $10.46 | 8,324,000 |
About Novavax, Inc.
Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the COVID-19 vaccine. The company was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
đ° Latest News
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
Zacks âĸ 2026-06-23T13:00:06Z
Novavax (NVAX) Stock Falls Amid Market Uptick: What Investors Need to Know
Zacks âĸ 2026-06-18T21:45:03Z
Moderna Is Up 94% This Year: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?
24/7 Wall St. âĸ 2026-06-16T19:21:15Z
A Look Back at Therapeutics Stocksâ Q1 Earnings: Novavax (NASDAQ:NVAX) Vs The Rest Of The Pack
StockStory âĸ 2026-06-16T18:33:04Z
Novavax (NVAX) Stock Slides as Market Rises: Facts to Know Before You Trade
Zacks âĸ 2026-06-12T21:45:04Z
Novavax Pivots To Matrix M Licensing As Sanofi Takes Europe
Simply Wall St. âĸ 2026-06-11T00:20:08Z
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
Zacks âĸ 2026-06-08T13:00:05Z
Novavax (NVAX) Up 10.4% Since Last Earnings Report: Can It Continue?
Zacks âĸ 2026-06-05T15:30:25Z
3 Cash-Burning Stocks We Think Twice About
StockStory âĸ 2026-06-04T17:33:30Z
Why Novavax (NVAX) Stock Is Trading Up Today
StockStory âĸ 2026-05-26T20:15:28Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $73,040,000 | $202,739,000 | $343,768,000 | $902,639,000 |
| Cost Of Revenue | $73,040,000 | $202,739,000 | $343,768,000 | $902,639,000 |
| Total Revenue | $1,123,479,000 | $682,162,000 | $556,382,000 | $1,598,951,000 |
| Operating Revenue | $1,123,479,000 | $682,162,000 | $556,382,000 | $1,598,951,000 |
| Expenses | ||||
| Interest Expense | $22,547,000 | $20,075,000 | $14,416,000 | $19,880,000 |
| Total Expenses | $572,839,000 | $931,093,000 | $1,122,893,000 | $2,243,687,000 |
| Other Income Expense | $-85,926,000 | $92,391,000 | $37,896,000 | $10,969,000 |
| Other Non Operating Income Expenses | $40,633,000 | $40,442,000 | $37,896,000 | $10,969,000 |
| Net Non Operating Interest Income Expense | $-22,547,000 | $-20,075,000 | $-14,416,000 | $-19,880,000 |
| Interest Expense Non Operating | $22,547,000 | $20,075,000 | $14,416,000 | $19,880,000 |
| Operating Expense | $499,799,000 | $728,354,000 | $779,125,000 | $1,341,048,000 |
| Other Operating Expenses | - | - | $-427,323,000 | $-382,921,000 |
| General And Administrative Expense | - | - | - | $488,691,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $440,302,000 | $-187,499,000 | $-545,062,000 | $-657,939,000 |
| Net Interest Income | $-22,547,000 | $-20,075,000 | $-14,416,000 | $-19,880,000 |
| Normalized Income | $566,861,000 | $-228,538,710 | $-545,062,000 | $-657,939,000 |
| Net Income From Continuing And Discontinued Operation | $440,302,000 | $-187,499,000 | $-545,062,000 | $-657,939,000 |
| Total Operating Income As Reported | $452,795,000 | $-248,931,000 | $-566,511,000 | $-644,736,000 |
| Average Dilution Earnings | $5,442,000 | $0 | $0 | - |
| Net Income Common Stockholders | $440,302,000 | $-187,499,000 | $-545,062,000 | $-657,939,000 |
| Net Income | $440,302,000 | $-187,499,000 | $-545,062,000 | $-657,939,000 |
| Net Income Including Noncontrolling Interests | $440,302,000 | $-187,499,000 | $-545,062,000 | $-657,939,000 |
| Net Income Continuous Operations | $440,302,000 | $-187,499,000 | $-545,062,000 | $-657,939,000 |
| Pretax Income | $442,167,000 | $-176,615,000 | $-543,031,000 | $-653,647,000 |
| Special Income Charges | $-126,559,000 | $51,949,000 | $0 | $0 |
| Operating Income | $550,640,000 | $-248,931,000 | $-566,511,000 | $-644,736,000 |
| Gross Profit | $1,050,439,000 | $479,423,000 | $212,614,000 | $696,312,000 |
| Per Share | ||||
| Diluted EPS | $2.58 | $-1.23 | $-5.41 | $-8.42 |
| Basic EPS | $2.72 | $-1.23 | $-5.41 | $-8.42 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $10,909,290 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $618,886,000 | $-159,993,000 | $-487,390,000 | $-604,713,000 |
| Total Unusual Items | $-126,559,000 | $51,949,000 | $0 | $0 |
| Total Unusual Items Excluding Goodwill | $-126,559,000 | $51,949,000 | $0 | $0 |
| Reconciled Depreciation | $27,613,000 | $48,496,000 | $41,225,000 | $29,054,000 |
| EBITDA (Bullshit earnings) | $492,327,000 | $-108,044,000 | $-487,390,000 | $-604,713,000 |
| EBIT | $464,714,000 | $-156,540,000 | $-528,615,000 | $-633,767,000 |
| Diluted Average Shares | $173,103,000 | $152,190,000 | $100,768,000 | $78,183,000 |
| Basic Average Shares | $161,991,000 | $152,190,000 | $100,768,000 | $78,183,000 |
| Diluted NI Availto Com Stockholders | $445,744,000 | $-187,499,000 | $-545,062,000 | $-657,939,000 |
| Tax Provision | $1,865,000 | $10,884,000 | $2,031,000 | $4,292,000 |
| Gain On Sale Of Ppe | $0 | $51,949,000 | $0 | $0 |
| Other Special Charges | $28,714,000 | - | - | - |
| Write Off | $97,845,000 | $0 | $0 | - |
| Research And Development | $342,320,000 | $391,169,000 | $737,502,000 | $1,235,278,000 |
| Selling General And Administration | $157,479,000 | $337,185,000 | $468,946,000 | $488,691,000 |
| Other Gand A | - | - | - | $488,691,000 |
| Gain On Sale Of Security | - | - | - | - |
Fetched: 2026-06-22
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-241,215,000 | $-731,319,000 | $-844,381,000 | $-760,409,000 |
| Total Assets | $1,176,512,000 | $1,560,418,000 | $1,797,490,000 | $2,258,679,000 |
| Total Non Current Assets | $198,236,000 | $431,476,000 | $653,602,000 | $555,288,000 |
| Other Non Current Assets | $17,077,000 | $24,000,000 | $35,159,000 | $28,469,000 |
| Goodwill And Other Intangible Assets | $113,462,000 | $107,478,000 | $127,454,000 | $126,331,000 |
| Current Assets | $978,276,000 | $1,128,942,000 | $1,143,888,000 | $1,703,391,000 |
| Other Current Assets | $9,870,000 | $21,888,000 | $155,726,000 | $76,374,000 |
| Assets Held For Sale Current | $87,510,000 | $0 | - | - |
| Restricted Cash | $10,876,000 | $10,626,000 | $10,424,000 | $10,303,000 |
| Prepaid Assets | $16,945,000 | $56,276,000 | $70,297,000 | $160,773,000 |
| Inventory | $11,545,000 | $8,749,000 | $41,696,000 | $36,683,000 |
| Receivables | $106,446,000 | $108,285,000 | $297,240,000 | $82,375,000 |
| Accounts Receivable | $106,446,000 | $108,285,000 | $297,240,000 | $82,375,000 |
| Cash Cash Equivalents And Short Term Investments | $735,084,000 | $923,118,000 | $568,505,000 | $1,336,883,000 |
| Cash And Cash Equivalents | $240,634,000 | $530,230,000 | $568,505,000 | $1,336,883,000 |
| Other Intangible Assets | - | - | - | - |
| Cash Equivalents | - | - | - | - |
| Cash Financial | - | - | - | - |
| Debt | ||||
| Net Debt | $3,579,000 | - | - | - |
| Total Debt | $248,811,000 | $230,419,000 | $229,081,000 | $549,781,000 |
| Long Term Debt And Capital Lease Obligation | $246,304,000 | $223,410,000 | $223,939,000 | $197,704,000 |
| Long Term Debt | $244,213,000 | $169,684,000 | $168,016,000 | $166,466,000 |
| Current Debt And Capital Lease Obligation | $2,507,000 | $7,009,000 | $5,142,000 | $352,077,000 |
| Current Debt | - | - | - | $324,881,000 |
| Other Current Borrowings | - | - | - | $324,881,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $1,304,265,000 | $2,184,259,000 | $2,514,417,000 | $2,892,757,000 |
| Total Non Current Liabilities Net Minority Interest | $844,315,000 | $1,029,843,000 | $879,279,000 | $432,813,000 |
| Other Non Current Liabilities | $239,068,000 | $359,614,000 | $33,130,000 | $55,695,000 |
| Non Current Deferred Liabilities | $358,943,000 | $446,819,000 | $622,210,000 | $179,414,000 |
| Current Liabilities | $459,950,000 | $1,154,416,000 | $1,635,138,000 | $2,459,944,000 |
| Other Current Liabilities | $185,647,000 | $219,596,000 | $861,408,000 | $930,055,000 |
| Current Deferred Liabilities | $140,053,000 | $675,067,000 | $241,310,000 | $370,137,000 |
| Payables And Accrued Expenses | $80,768,000 | $192,394,000 | $471,326,000 | $755,106,000 |
| Payables | $24,578,000 | $41,579,000 | $132,610,000 | $216,517,000 |
| Accounts Payable | $24,578,000 | $41,579,000 | $132,610,000 | $216,517,000 |
| Equity | ||||
| Common Stock Equity | $-127,753,000 | $-623,841,000 | $-716,927,000 | $-634,078,000 |
| Total Equity Gross Minority Interest | $-127,753,000 | $-623,841,000 | $-716,927,000 | $-634,078,000 |
| Stockholders Equity | $-127,753,000 | $-623,841,000 | $-716,927,000 | $-634,078,000 |
| Gains Losses Not Affecting Retained Earnings | $2,010,000 | $-22,559,000 | $2,722,000 | $-6,377,000 |
| Other Equity Adjustments | $2,010,000 | $-22,559,000 | $2,722,000 | $-6,377,000 |
| Retained Earnings | $-4,568,148,000 | $-5,008,450,000 | $-4,820,951,000 | $-4,275,889,000 |
| Preferred Securities Outside Stock Equity | $0 | $0 | $0 | $0 |
| Other | ||||
| Treasury Shares Number | $2,393,836 | $1,521,541 | $1,000,323 | $766,631 |
| Ordinary Shares Number | $162,575,937 | $160,421,136 | $139,505,770 | $86,039,923 |
| Share Issued | $164,969,773 | $161,942,677 | $140,506,093 | $86,806,554 |
| Tangible Book Value | $-241,215,000 | $-731,319,000 | $-844,381,000 | $-760,409,000 |
| Invested Capital | $116,460,000 | $-454,157,000 | $-548,911,000 | $-142,731,000 |
| Working Capital | $518,326,000 | $-25,474,000 | $-491,250,000 | $-756,553,000 |
| Capital Lease Obligations | $4,598,000 | $60,735,000 | $61,065,000 | $58,434,000 |
| Total Capitalization | $116,460,000 | $-454,157,000 | $-548,911,000 | $-467,612,000 |
| Treasury Stock | $103,021,000 | $95,854,000 | $92,267,000 | $90,659,000 |
| Additional Paid In Capital | $4,539,756,000 | $4,501,403,000 | $4,192,164,000 | $3,737,979,000 |
| Capital Stock | $1,650,000 | $1,619,000 | $1,405,000 | $868,000 |
| Common Stock | $1,650,000 | $1,619,000 | $1,405,000 | $868,000 |
| Non Current Deferred Revenue | $358,943,000 | $446,819,000 | $622,210,000 | $179,414,000 |
| Long Term Capital Lease Obligation | $2,091,000 | $53,726,000 | $55,923,000 | $31,238,000 |
| Current Deferred Revenue | $140,053,000 | $675,067,000 | $241,310,000 | $370,137,000 |
| Current Capital Lease Obligation | $2,507,000 | $7,009,000 | $5,142,000 | $27,196,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $50,975,000 | $60,350,000 | $55,952,000 | $52,569,000 |
| Current Accrued Expenses | $56,190,000 | $150,815,000 | $338,716,000 | $538,589,000 |
| Goodwill | $113,462,000 | $107,478,000 | $127,454,000 | $126,331,000 |
| Net PPE | $67,697,000 | $299,998,000 | $490,989,000 | $400,488,000 |
| Accumulated Depreciation | $-40,621,000 | $-49,157,000 | $-74,968,000 | $-47,292,000 |
| Gross PPE | $108,318,000 | $349,155,000 | $565,957,000 | $447,780,000 |
| Leases | $31,249,000 | $66,886,000 | $48,310,000 | $18,895,000 |
| Construction In Progress | $6,272,000 | $39,513,000 | $76,156,000 | $81,566,000 |
| Other Properties | $22,897,000 | $161,585,000 | $185,218,000 | $106,241,000 |
| Machinery Furniture Equipment | $47,900,000 | $66,226,000 | $153,357,000 | $139,736,000 |
| Land And Improvements | $0 | $14,945,000 | $102,916,000 | $101,342,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $1,342,000 | $1,763,000 | $27,690,000 | $1,361,000 |
| Work In Process | $7,591,000 | $4,899,000 | $7,392,000 | $21,410,000 |
| Raw Materials | $2,612,000 | $2,087,000 | $6,614,000 | $13,912,000 |
| Other Short Term Investments | $494,450,000 | $392,888,000 | $0 | - |
| Preferred Stock | - | - | $0 | $0 |
Fetched: 2026-06-22
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-251,023,000 | $-101,902,000 | $-772,773,000 | $-508,922,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-244,635,000 | $-87,263,000 | $-713,967,000 | $-415,937,000 |
| Cash Flow From Continuing Operating Activities | $-244,635,000 | $-87,263,000 | $-713,967,000 | $-415,937,000 |
| Operating Gains Losses | $28,714,000 | $-51,949,000 | - | - |
| Investing Activities | ||||
| Capital Expenditure | $-6,388,000 | $-14,639,000 | $-58,806,000 | $-92,985,000 |
| Investing Cash Flow | $-78,267,000 | $-204,038,000 | $-58,806,000 | $-92,985,000 |
| Cash Flow From Continuing Investing Activities | $-78,267,000 | $-204,038,000 | $-58,806,000 | $-92,985,000 |
| Net Other Investing Changes | $19,653,000 | $192,643,000 | - | - |
| Capital Expenditure Reported | $-5,560,000 | $-13,057,000 | $-53,771,000 | $-89,056,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $0 | $263,272,000 | $360,243,000 | $249,230,000 |
| Financing Cash Flow | $27,737,000 | $260,583,000 | $4,466,000 | $324,988,000 |
| Cash Flow From Continuing Financing Activities | $27,737,000 | $260,583,000 | $4,466,000 | $324,988,000 |
| Net Common Stock Issuance | $0 | $263,272,000 | $360,243,000 | $249,230,000 |
| Common Stock Issuance | $0 | $263,272,000 | $360,243,000 | $249,230,000 |
| Net Other Financing Charges | - | - | $-3,591,000 | $-5,258,000 |
| Net Preferred Stock Issuance | - | - | - | $0 |
| Preferred Stock Issuance | - | - | - | $0 |
| Other | ||||
| Repayment Of Debt | $-10,071,000 | $-3,994,000 | $-352,345,000 | $-93,595,000 |
| Issuance Of Debt | $42,606,000 | $0 | $0 | $175,250,000 |
| Interest Paid Supplemental Data | $15,047,000 | $17,572,000 | $17,349,000 | $18,035,000 |
| Income Tax Paid Supplemental Data | $8,806,000 | $949,000 | $190,000 | $17,980,000 |
| End Cash Position | $256,052,000 | $545,292,000 | $583,810,000 | $1,348,845,000 |
| Beginning Cash Position | $545,292,000 | $583,810,000 | $1,348,845,000 | $1,528,259,000 |
| Effect Of Exchange Rate Changes | $5,925,000 | $-7,800,000 | $3,272,000 | $4,520,000 |
| Changes In Cash | $-295,165,000 | $-30,718,000 | $-768,307,000 | $-183,934,000 |
| Proceeds From Stock Option Exercised | $-4,798,000 | $1,305,000 | $159,000 | $-639,000 |
| Net Issuance Payments Of Debt | $32,535,000 | $-3,994,000 | $-352,345,000 | $81,655,000 |
| Net Long Term Debt Issuance | $32,535,000 | $-3,994,000 | $-352,345,000 | $81,655,000 |
| Long Term Debt Payments | $-10,071,000 | $-3,994,000 | $-352,345,000 | $-93,595,000 |
| Long Term Debt Issuance | $42,606,000 | $0 | $0 | $175,250,000 |
| Net Investment Purchase And Sale | $-91,532,000 | $-382,042,000 | $0 | $0 |
| Sale Of Investment | $353,735,000 | $443,551,000 | $0 | $0 |
| Purchase Of Investment | $-445,267,000 | $-825,593,000 | $0 | $0 |
| Net Intangibles Purchase And Sale | $-828,000 | $-1,582,000 | $-5,035,000 | $-3,929,000 |
| Change In Working Capital | $-887,705,000 | $48,482,000 | $-376,836,000 | $-361,150,000 |
| Change In Other Working Capital | $-622,939,000 | $67,105,000 | $350,868,000 | $-1,045,914,000 |
| Change In Payables And Accrued Expense | $-322,566,000 | $-385,626,000 | $-378,805,000 | $913,399,000 |
| Change In Payable | $-322,566,000 | $-385,626,000 | $-378,805,000 | $913,399,000 |
| Change In Account Payable | $-322,566,000 | $-385,626,000 | $-378,805,000 | $913,399,000 |
| Change In Inventory | $-3,240,000 | $12,914,000 | $-74,457,000 | $-477,801,000 |
| Change In Receivables | $61,040,000 | $354,089,000 | $-274,442,000 | $249,166,000 |
| Changes In Account Receivables | $61,040,000 | $354,089,000 | $-274,442,000 | $249,166,000 |
| Other Non Cash Items | $5,756,000 | $-18,047,000 | $-929,000 | $-3,799,000 |
| Stock Based Compensation | $36,015,000 | $48,152,000 | $85,357,000 | $130,300,000 |
| Provisionand Write Offof Assets | $1,945,000 | $20,970,000 | $72,197,000 | $447,597,000 |
| Asset Impairment Charge | $102,725,000 | $4,132,000 | $10,081,000 | $0 |
| Depreciation Amortization Depletion | $27,613,000 | $48,496,000 | $41,225,000 | $29,054,000 |
| Depreciation And Amortization | $27,613,000 | $48,496,000 | $41,225,000 | $29,054,000 |
| Net Income From Continuing Operations | $440,302,000 | $-187,499,000 | $-545,062,000 | $-657,939,000 |
| Net Business Purchase And Sale | - | - | - | $0 |
| Purchase Of Business | - | - | - | $0 |
| Purchase Of Intangibles | - | - | - | $-3,929,000 |
Fetched: 2026-06-22